Sputum microRNA-screening reveals Prostaglandin EP3 receptor as selective target in allergen-specific immunotherapy

mehr
Titel Sputum microRNA-screening reveals Prostaglandin EP3 receptor as selective target in allergen-specific immunotherapy
Medien Clinical & Experimental Allergy
Verfasser Constanze Jakwerth, Adam Chaker, Ferdinand Guerth, Madlen Oelsner, Lisa Pechtold, Lynn Zur Bonsen, Julia Ullmann, Susanne Krauss-Etschmann, Anna Erb, Josephine Kau, Mirjam Plaschke, Marlene Winkler, Alexandra Kurz, Antonia Kloss, Julia Esser-von Bieren, Carsten Schmidt-Weber, Ulrich Zissler, Prof. Dr. Ulrich Zißler
Veröffentlichungsdatum 01.01.2021
Zitation Jakwerth, Constanze; Chaker, Adam; Guerth, Ferdinand; Oelsner, Madlen; Pechtold, Lisa; Zur Bonsen, Lynn; Ullmann, Julia; Krauss-Etschmann, Susanne; Erb, Anna; Kau, Josephine; Plaschke, Mirjam; Winkler, Marlene; Kurz, Alexandra; Kloss, Antonia; Esser-von Bieren, Julia; Schmidt-Weber, Carsten; Zissler, Ulrich; Zißler, Ulrich (2021): Sputum microRNA-screening reveals Prostaglandin EP3 receptor as selective target in allergen-specific immunotherapy. Clinical & Experimental Allergy. DOI: 10.1111/CEA.14013